Dr. reddy's successfully completes phase i study (iv route) of drl_tc, a proposed biosimilar of tocilizumab

Hyderabad, india--(business wire)---- $rdy #drl_tc--dr. reddy's announced that its tocilizumab biosimilar candidate, drl_tc, successfully met its primary and secondary endpoints in a phase i study.

RDY Ratings Summary

RDY Quant Ranking